NYSE : PBH
Prestige Consumer Healthcare Inc. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 49.06 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.32B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.32B |
| Enterprise Value | 4.30B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 47.37M |
| Shares Outstanding | 47.37M |
| Shares Change (YoY) | -3.62% |
| Shares Change (QoQ) | -0.17% |
| Owned by Insiders (%) | 1.41% |
| Owned by Institutions (%) | 114.56% |
| Float | 46.70M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 13.72 |
| Forward PE | 10.44 |
| PS Ratio | 2.10 |
| Forward PS | 1.71 |
| PB Ratio | 1.21 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.88 |
| P/OCF Ratio | 9.32 |
| PEG Ratio | 1.30 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 25.01 |
| EV / Sales | 3.89 |
| EV / EBITDA | 13.22 |
| EV / EBIT | 14.68 |
| EV / FCF | 18.28 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.23 |
| Quick Ratio | 1.80 |
| Debt / Equity | 1.08 |
| Debt / EBITDA | 5.86 |
| Debt / FCF | 8.78 |
| Interest Coverage | 6.36 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 9.12% |
| Return on Assets (ROA) | 4.58% |
| Return on Invested Capital (ROIC) | 6.36% |
| Return on Capital Employed (ROCE) | 6.64% |
| Weighted Average Cost of Capital (WACC) | 4.02% |
| Revenue Per Employee | $1.24M |
| Profits Per Employee | $193,272 |
| Employee Count | 890 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 2.91 |
Taxes
| Measure | Value |
|---|
| Income Tax | 62.25M |
| Effective Tax Rate | 26.57% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.34 |
| 52-Week Price Change | -19.19% |
| 50-Day Moving Average | 48.53 |
| 200-Day Moving Average | 54.09 |
| Relative Strength Index (RSI) | 54.14 |
| Average Volume (20 Days) | 516,794 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.96M |
| Short Previous Month | 4.79M |
| Short % of Shares Out | 8.36% |
| Short % of Float | 8.49% |
| Short Ratio (days to cover) | 6.28 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.10B |
| Gross Profit | 605.18M |
| Operating Income | 293.01M |
| Pretax Income | 234.26M |
| Net Income | 172.01M |
| EBITDA | 325.37M |
| EBIT | 293.01M |
| Earnings Per Share (EPS) | $3.58 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 89.13M |
| Total Debt | 2.07B |
| Net Cash | -1.98B |
| Net Cash Per Share | -$41.76 |
| Equity (Book Value) | 1.92B |
| Book Value Per Share | 40.46 |
| Working Capital | 343.01M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 249.40M |
| Capital Expenditures | -14.04M |
| Depreciation & Amortization | 32.36M |
| Net Borrowing | 1.05B |
| Free Cash Flow | 235.36M |
| FCF Per Share | $4.97 |
Margins
| Measure | Value |
|---|
| Gross Margin | 54.77% |
| Operating Margin | 26.52% |
| Pretax Margin | 21.20% |
| Profit Margin | 15.57% |
| EBITDA Margin | 29.45% |
| EBIT Margin | 26.52% |
| FCF Margin | 21.30% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 3.62% |
| Shareholder Yield | 3.62% |
| Earnings Yield | 7.29% |
| FCF Yield | 10.13% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $67.80 |
| Price Target Difference | 38.20% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 6.81% |
| EPS Growth Forecast (3Y) | 6.00% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.76 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |